She's trying to outrun pancreatic cancer. Breakthrough treatments give her hope - NPR

Vicky Stinson’s multi-month struggle to get a diagnosis and her treatment journey illustrate how recent advances are shifting pancreatic cancer care from almost uniformly fatal to an area with growing, if still cautious, optimism. The daraxonrasib findings — showing a roughly doubled survival time in advanced cases — add another tangible reason for hope and may expand options beyond vaccines and other experimental therapies. The story continues to underscore persistent challenges: diagnostic delays, unequal access, and the need for more trials to prove which new treatments will alter long-term outcomes.